Rydapt FDA Approved Drugs
RYDAPT [MidostaurinC35H30N4O4]
RX
- 25mg (oral capsule)
Novartis Pharms CorpApr 28, 2017
- Treatment of adult patients with aggressive systemic mastocytosis (asm), systemic mastocytosis with associated hematological neoplasm (sm-ahn), or mast cell leukemia (mcl).
- Treatment of adult patients with newly diagnosed acute myeloid leukemia (aml) who are flt3 mutation-positive, in combination with standard cytarabine and daunorubicin induction and cytarabine consolidation chemotherapy.
WARNING: Consult a licensed physician in the appropriate field for medical treatment and drug prescription. Do not self medicate.